Related references
Note: Only part of the references are listed.Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia
Franc Llorens et al.
ALZHEIMERS & DEMENTIA (2016)
Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease
Andre Karch et al.
NEUROBIOLOGY OF AGING (2015)
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort
N. S. M. Schoonenboom et al.
NEUROLOGY (2012)
Age and diagnostic performance of Alzheimer disease CSF biomarkers
N. Mattsson et al.
NEUROLOGY (2012)
Identifying and validating biomarkers for Alzheimer's disease
Christian Humpel
TRENDS IN BIOTECHNOLOGY (2011)
Clinical Features of Rapidly Progressive Alzheimer's Disease
Christian Schmidt et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
I. Zerr et al.
BRAIN (2009)
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Sebastiaan Engelborghs et al.
NEUROBIOLOGY OF AGING (2008)
Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2007)
Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance
U. Heinemann et al.
BRAIN (2007)
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
P. Sanchez-Juan et al.
NEUROLOGY (2006)
Total tau protein, phosphorylated tau (181p) protein, β-amyloid1-42, and β-amyloid1-40 in cerebrospinal fluid of patients with dementia with Lewy bodies
B Mollenhauer et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2006)
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease
M Otto et al.
NEUROLOGY (2002)
Both total and phosphorylated tau are increased in Alzheimer's disease
M Sjögren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Share Paper
